{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:44:55Z","timestamp":1791967495085,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Guillain-Barr\u00e9 syndrome (GBS) is among the most common causes of acute inflammatory polyneuropathy and may present with cranial nerve involvement, including facial diplegia. Rarely, hematologic malignancies can produce a GBS-compatible or GBS-like neurological phenotype, creating a diagnostic challenge in the acute setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 50-year-old immunocompetent woman presented with bilateral facial paralysis, dysarthria, dysphagia, areflexia, and mild left upper-limb weakness. Cerebrospinal fluid (CSF) analysis showed albuminocytologic dissociation. Baseline electromyography and nerve conduction studies (EMG\/NCS), performed early in the course, showed non-specific sensorimotor polyneuropathy without definitive demyelinating features. Because the clinical syndrome and CSF findings were compatible with a time-sensitive working diagnosis of GBS, intravenous immunoglobulin was initiated. Follow-up EMG\/NCS in the second week evolved to show demyelinating features with secondary axonal involvement, compatible with GBS. However, rapidly progressive leukocytosis, markedly elevated lactate dehydrogenase and ferritin levels, profound weight loss, splenomegaly, para-aortic lymphadenopathy, and blast-like cells on peripheral smear prompted parallel hematologic reassessment. Peripheral blood flow cytometry was consistent with Burkitt lymphoma, and repeat CSF flow cytometry demonstrated a CD10\u2009+\u2009germinal center-derived B-cell neoplastic population, indicating central nervous system involvement. The patient subsequently deteriorated with aspiration pneumonia, sepsis\/shock, and a fatal course before lymphoma-directed chemotherapy could be initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Burkitt lymphoma with central nervous system involvement can present with a GBS-compatible acute neuropathic phenotype, including facial diplegia. The initial diagnosis of GBS may be clinically reasonable in a time-sensitive setting; however, major systemic and hematologic red flags should prompt early parallel evaluation for malignancy. Peripheral blood and CSF flow cytometry may provide decisive diagnostic evidence when biopsy or further work-up is not feasible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-05153-4","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:35:09Z","timestamp":1784381709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Facial diplegia as the first manifestation of Burkitt lymphoma with a Guillain-Barr\u00e9 syndrome\u2013like presentation: a case report"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8656-1165","authenticated-orcid":false,"given":"Irem Yagmur","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Kasim","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu Ozen","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"10280","key":"5153_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021;397(10280):1214\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(21)00517-1.","journal-title":"Lancet"},{"issue":"6","key":"5153_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mus.24887","volume":"52","author":"BR Wakerley","year":"2015","unstructured":"Wakerley BR, Yuki N. Isolated facial diplegia in Guillain-Barr\u00e9 syndrome: bifacial weakness with paresthesias. Muscle Nerve. 2015;52(6):927\u201332. https:\/\/doi.org\/10.1002\/mus.24887.","journal-title":"Muscle Nerve"},{"key":"5153_CR3","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1007\/s00415-023-11897-7","volume":"270","author":"G Molinari","year":"2023","unstructured":"Molinari G, Lucidi D, De Corso E, et al. Acquired bilateral facial palsy: a systematic review on aetiologies and management. J Neurol. 2023;270:4303\u201315. https:\/\/doi.org\/10.1007\/s00415-023-11897-7.","journal-title":"J Neurol"},{"issue":"4","key":"5153_CR4","doi-asserted-by":"publisher","first-page":"e14671","DOI":"10.7759\/cureus.14671","volume":"13","author":"A Yang","year":"2021","unstructured":"Yang A, Dalal V. Bilateral facial palsy: a clinical approach. Cureus. 2021;13(4):e14671. https:\/\/doi.org\/10.7759\/cureus.14671.","journal-title":"Cureus"},{"issue":"5","key":"5153_CR5","doi-asserted-by":"publisher","first-page":"e00960","DOI":"10.1002\/brb3.960","volume":"8","author":"SL Tham","year":"2018","unstructured":"Tham SL, Prasad K, Umapathi T. Guillain-Barr\u00e9 syndrome mimics. Brain Behav. 2018;8(5):e00960. https:\/\/doi.org\/10.1002\/brb3.960.","journal-title":"Brain Behav"},{"issue":"3","key":"5153_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/cei.12185","volume":"175","author":"F Leypoldt","year":"2014","unstructured":"Leypoldt F, Wandinger KP. Paraneoplastic neurological syndromes. Clin Exp Immunol. 2014;175(3):336\u201348.","journal-title":"Clin Exp Immunol"},{"issue":"1\u20132","key":"5153_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2015.06.003","volume":"355","author":"JP St\u00fcbgen","year":"2015","unstructured":"St\u00fcbgen JP. Lymphoma-associated dysimmune polyneuropathies. J Neurol Sci. 2015;355(1\u20132):25\u201336. https:\/\/doi.org\/10.1016\/j.jns.2015.06.003.","journal-title":"J Neurol Sci"},{"issue":"4","key":"5153_CR8","doi-asserted-by":"publisher","first-page":"e209698","DOI":"10.1212\/WNL.0000000000209698","volume":"103","author":"LD Kaulen","year":"2024","unstructured":"Kaulen LD, Ehlers J, Hempel A, et al. Clinical presentation, management, and outcome in neurolymphomatosis. Neurology. 2024;103(4):e209698.","journal-title":"Neurology"},{"issue":"1","key":"5153_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s44276-024-00053-x","volume":"2","author":"E Xu","year":"2024","unstructured":"Xu E, Zhu W, Xu Y, et al. The natural history of neurolymphomatosis: a meta-analysis. BJC Rep. 2024;2(1):5.","journal-title":"BJC Rep"},{"issue":"5","key":"5153_CR10","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/bloodadvances.2020003666","volume":"5","author":"A Khurana","year":"2021","unstructured":"Khurana A, Novo M, Nowakowski GS, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era. Blood Adv. 2021;5(5):1379\u201387. https:\/\/doi.org\/10.1182\/bloodadvances.2020003666.","journal-title":"Blood Adv"},{"issue":"1","key":"5153_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cyto.b.21487","volume":"94","author":"M n der Meulen","year":"2018","unstructured":"n der Meulen M, van den Doodeman HJ, et al. Flow cytometry has added value in diagnosing leptomeningeal dissemination. Cytometry B Clin Cytom. 2018;94(1):143\u201351.","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"5153_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","volume":"86","author":"YA Rajabally","year":"2015","unstructured":"Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86(1):115\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"5153_CR13","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.clinph.2012.01.025","volume":"123","author":"A Uncini","year":"2012","unstructured":"Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barr\u00e9 syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123(8):1487\u201395. https:\/\/doi.org\/10.1016\/j.clinph.2012.01.025.","journal-title":"Clin Neurophysiol"},{"key":"5153_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019;15:671\u201383.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"5153_CR15","first-page":"2179","volume":"30","author":"PA van Doorn","year":"2023","unstructured":"van Doorn PA, Hadden RDM, et al. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome. Eur J Neurol. 2023;30(8):2179\u201395.","journal-title":"Eur J Neurol"},{"key":"5153_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jocn.2023.01.003","volume":"110","author":"JC L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez JC, Rivas-Cruz MA, Galnares-Olalde JA, et al. Sural nerve involvement in Guillain-Barr\u00e9 syndrome: clinical and prognostic implications. A prospective cohort. J Clin Neurosci. 2023;110:48\u201352. https:\/\/doi.org\/10.1016\/j.jocn.2023.01.003.","journal-title":"J Clin Neurosci"},{"key":"5153_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C van den Fokke","year":"2014","unstructured":"van den Fokke C, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137:33\u201343.","journal-title":"Brain"},{"issue":"10045","key":"5153_CR18","first-page":"717","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome Lancet. 2016;388(10045):717\u201327.","journal-title":"Guillain-Barr\u00e9 syndrome Lancet"},{"issue":"4","key":"5153_CR19","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/j.clml.2020.01.012","volume":"20","author":"L Fitzgerald","year":"2020","unstructured":"Fitzgerald L, Stephens DM. Burkitt lymphoma presenting as cranial multineuritis secondary to primary neurolymphomatosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2020;20(4):e201\u20134. https:\/\/doi.org\/10.1016\/j.clml.2020.01.012.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"5153_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/neup.13003","volume":"45","author":"D Colombo","year":"2025","unstructured":"Colombo D, Falasca L, Monardo F, et al. Neurolymphomatosis mimicking a Guillain-Barr\u00e9 syndrome triggered by COVID-19 vaccination. Neuropathology. 2025;45(1):76\u201382. https:\/\/doi.org\/10.1111\/neup.13003.","journal-title":"Neuropathology"},{"issue":"10","key":"5153_CR21","doi-asserted-by":"publisher","first-page":"005764","DOI":"10.12890\/2025_005764","volume":"12","author":"V Petrakis","year":"2025","unstructured":"Petrakis V, Tartanis G, Tsakaldimi S, et al. Guillain-Barr\u00e9 syndrome as the initial clinical manifestation of Hodgkin\u2019s lymphoma. Eur J Case Rep Intern Med. 2025;12(10):005764. https:\/\/doi.org\/10.12890\/2025_005764.","journal-title":"Eur J Case Rep Intern Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05153-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:49:19Z","timestamp":1791964159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05153-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5153"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05153-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patient\u2019s next of kin.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"648"}}